Iliopelvic lymphoscintigraphy as a predictor of early metastatic disease in patients with prostate carcinoma.
Clin Nucl Med
; 17(5): 357-60, 1992 May.
Article
em En
| MEDLINE
| ID: mdl-1587039
ABSTRACT
Fifty-one patients had iliopelvic lymphoscintigraphy (IPL) as part of the initial assessment of newly diagnosed prostate carcinoma over a 3-year period. Investigations other than IPL showed that all patients had disease confined to the prostate, and they received radiotherapy to the prostate and regional pelvic lymph nodes. Patients with complete absence of activity in an iliac chain on IPL were excluded from the analysis because that finding could have resulted from tumor replacement or a failed injection. Of the remaining 41 patients, 12 had abnormal scintigrams, and 6 (50%) had recurrence within a mean 15-month follow-up period. Of 29 patients with normal scintigrams, 26 (90%) remain disease free over an average 27-month follow-up period.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Pélvicas
/
Neoplasias da Próstata
/
Compostos de Tecnécio
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin Nucl Med
Ano de publicação:
1992
Tipo de documento:
Article
País de afiliação:
Canadá